DOX Price Prediction Next Week
Technical Analysis
Based on the technical indicators and Fibonacci levels, DOX is currently trading near its pivot point of $87.93. The RSI(14) at 51.18 indicates a neutral momentum, neither overbought nor oversold. The stock is trading above both its 20-day SMA ($86.01) and 200-day SMA ($84.25), suggesting a generally positive trend.
News Analysis
Recent news shows several significant developments:
- DOX will report earnings after market close today
- The company maintains a strong dividend profile with a 2.2% yield and consistent dividend growth history
- The stock is included in the Dividend Channel International S.A.F.E. 10 list, representing 1.64% of the Powershares International Dividend Achievers ETF (PID)
Price Prediction for Next Week
Based on Fibonacci levels:
- Resistance levels: R1: $90.45, R2: $92.00, R3: $94.52
- Support levels: S1: $85.41, S2: $83.86, S3: $81.34
Trading Recommendation
SELL with the following reasoning:
- The stock is approaching key resistance levels around $90.45
- With earnings report coming after market close today, historical patterns suggest potential volatility
- The neutral RSI indicates limited upward momentum in the short term
Target price range for next week: $85.41 - $87.93
DOX Similar Chart Price Prediction
The price of DOX is predicted to go up -2.93%, based on the high correlation periods with COTY. The similarity of these two price pattern on the periods is 93.58%.
DOX
COTY
Down: -2.93%Similarity: 93.58%
DOX Revenue Forecast
DOX EPS Forecast
DOX FAQs
What is bull’s view on DOX?
What is bear's view on DOX?
What is DOX revenue forecast for next quarter？
What is DOX eps forecast for next quarter？
DOX Analyst's Forecast
Tavy Rosner
Barclays
Buy
2024-11-14
Price Target
$113 → $111
Upside
+29.51%
Barclays lowered the firm's price target on Amdocs to $111 from $113 and keeps an Overweight rating on the shares following the CEO roadshow. The company is phasing out low-margin non-core businesses in a move that management indicated will boost recurring revenue and bring fiscal 2025 operating margin north of 21% while delivering double-digit shareholder return, the analyst tells investors in a research note.
Timothy Horan
Oppenheimer
Buy
2024-11-13
Price Target
$98 → $105
Upside
+19.66%
